|
Fusion gene ID: 3700 |
FusionGeneSummary for B3GALNT2_LBR |
Fusion gene summary |
Fusion gene information | Fusion gene name: B3GALNT2_LBR | Fusion gene ID: 3700 | Hgene | Tgene | Gene symbol | B3GALNT2 | LBR | Gene ID | 148789 | 3930 |
Gene name | beta-1,3-N-acetylgalactosaminyltransferase 2 | lamin B receptor | |
Synonyms | B3GalNAc-T2|MDDGA11 | DHCR14B|LMN2R|PHA|TDRD18 | |
Cytomap | 1q42.3 | 1q42.12 | |
Type of gene | protein-coding | protein-coding | |
Description | UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2UDP-GalNAc:betaGlcNAc beta-1,3-galactosaminyltransferase, polypeptide 2beta-1,3-GalNAc-T2 | lamin-B receptorintegral nuclear envelope inner membrane proteintudor domain containing 18 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q8NCR0 | Q14739 | |
Ensembl transtripts involved in fusion gene | ENST00000366600, ENST00000313984, ENST00000494378, | ENST00000272163, ENST00000338179, ENST00000487054, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 2 X 2 X 2=8 |
# samples | 3 | 2 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: B3GALNT2 [Title/Abstract] AND LBR [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | B3GALNT2 | GO:0006493 | protein O-linked glycosylation | 23929950 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | SARC | TCGA-DX-AB2H-01A | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000366600 | ENST00000272163 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
5CDS-5UTR | ENST00000366600 | ENST00000338179 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
5CDS-intron | ENST00000366600 | ENST00000487054 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
5CDS-5UTR | ENST00000313984 | ENST00000272163 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
5CDS-5UTR | ENST00000313984 | ENST00000338179 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
5CDS-intron | ENST00000313984 | ENST00000487054 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
intron-5UTR | ENST00000494378 | ENST00000272163 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
intron-5UTR | ENST00000494378 | ENST00000338179 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
intron-intron | ENST00000494378 | ENST00000487054 | B3GALNT2 | chr1 | 235634164 | - | LBR | chr1 | 225611791 | - |
Top |
FusionProtFeatures for B3GALNT2_LBR |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
B3GALNT2 | LBR |
Beta-1,3-N-acetylgalactosaminyltransferase thatsynthesizes a unique carbohydrate structure, GalNAc-beta-1-3GlcNAc, on N- and O-glycans. Has no galactose nor galactosaminyltransferase activity toward any acceptor substrate. Involved inalpha-dystroglycan (DAG1) glycosylation: acts coordinately withGTDC2/POMGnT2 to synthesize a GalNAc-beta3-GlcNAc-beta-terminus atthe 4-position of protein O-mannose in the biosynthesis of thephosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), acarbohydrate structure present in alpha-dystroglycan, which isrequired for binding laminin G-like domain-containingextracellular proteins with high affinity.{ECO:0000269|PubMed:14724282, ECO:0000269|PubMed:23453667,ECO:0000269|PubMed:23929950}. | Anchors the lamina and the heterochromatin to the innernuclear membrane. {ECO:0000269|PubMed:10828963}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for B3GALNT2_LBR |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for B3GALNT2_LBR |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
B3GALNT2 | FBXO6, NXF1, NRG1, IDS, PARP16, AGMAT, SFRP4, CHST8, FBXW7, OS9, EIF2B2, YY1AP1, TAZ, TRIM25 | LBR | CBX3, CBX5, YWHAG, AKAP8L, MECP2, HIST1H3A, HIST2H4A, ARRB2, TCF3, PPP1CA, PPP1CB, PPP1CC, KCND3, DHX9, HNRNPU, ILF2, HNRNPR, EIF4A3, DHX15, LMNA, CLK3, HIPK4, CUL7, OBSL1, EED, LUC7L, NTRK1, SRPK2, TCTN2, TCTN3, EVC2, TMEM17, TMEM216, GOLT1B, HYPK, CDH1, MAD2L1BP, ZNF579, CHTOP, BHLHA15, CLEC3A, DLST, PDHA1, G3BP1, UBE2A, PSMD3, CDK20 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for B3GALNT2_LBR |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for B3GALNT2_LBR |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | B3GALNT2 | C3554638 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11 | 1 | UNIPROT |
Tgene | LBR | C0030779 | Pelger-Huet Anomaly | 1 | CTD_human;HPO;UNIPROT |
Tgene | LBR | C0748397 | Reynolds syndrome | 1 | CTD_human;ORPHANET;UNIPROT |